Literature DB >> 24371581

Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

Laura Pisapia1, Giovanna Del Pozzo1, Pasquale Barba1, Alessandra Citro2, Paul E Harris2, Antonella Maffei3.   

Abstract

We previously demonstrated that, in ex vivo cultures, IFNα downregulates the expression of MHC class II (MHCII) genes in human non-professional APCs associated with pancreatic islets. IFNα has an opposing effect on MHCII expression in professional APCs. In this study, we found that the mechanism responsible for the IFNα-mediated MHCII's downregulation in human MHCII-positive non-professional antigen presenting human non-hematopoietic cell lines is the result of the negative feedback system that regulates cytokine signal transduction, which eventually inhibits promoters III and IV of CIITA gene. Because the CIITA-PIV isoform is mostly responsible for the constitutive expression of MHCII genes in non-professional APCs, we pursued and achieved the specific knockdown of CIITA-PIV mRNA in our in vitro system, obtaining a partial silencing of MHCII molecules similar to that obtained by IFNα. We believe that our results offer a new understanding of the potential significance of CIITA-PIV as a therapeutic target for interventional strategies that can manage autoimmune disease and allograft rejection with little interference on the function of professional APCs of the immune system.

Entities:  

Keywords:  CIITA promoter IV; IFNα; MHCII; Non-professional antigen presenting cells

Year:  2012        PMID: 24371581      PMCID: PMC3862382          DOI: 10.1016/j.rinim.2012.09.001

Source DB:  PubMed          Journal:  Results Immunol        ISSN: 2211-2839


  77 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.

Authors:  D Nandan; N E Reiner
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

3.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  CD4(+) T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro.

Authors:  M S Brady; F Lee; H Petrie; D D Eckels; J S Lee
Journal:  Cancer Immunol Immunother       Date:  2000-02       Impact factor: 6.968

5.  Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells.

Authors:  Suyun Huang; Corazon D Bucana; Melissa Van Arsdall; Isaiah J Fidler
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

6.  Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.

Authors:  Gregory B Lesinski; John Trefry; Melanie Brasdovich; Sri Vidya Kondadasula; Korkor Sackey; Jason M Zimmerer; Abhik Ray Chaudhury; Lianbo Yu; Xiaoli Zhang; Tim R Crespin; Michael J Walker; William E Carson
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

Review 7.  Endothelial cells in allograft rejection.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

8.  IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha.

Authors:  Mélanie Giroux; Manuel Schmidt; Albert Descoteaux
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

9.  Role of STAT2 in the alpha interferon signaling pathway.

Authors:  S Leung; S A Qureshi; I M Kerr; J E Darnell; G R Stark
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

10.  aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.

Authors:  R S Accolla; M Jotterand-Bellomo; L Scarpellino; A Maffei; G Carra; J Guardiola
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  3 in total

Review 1.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

2.  Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells.

Authors:  Jin Hong Liu; Yong Mei Bian; Yi Xie; Dao Pei Lu
Journal:  Mol Med Rep       Date:  2015-03-20       Impact factor: 2.952

3.  EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.

Authors:  Laura Pisapia; Pasquale Barba; Angela Cortese; Valeria Cicatiello; Franco Morelli; Giovanna Del Pozzo
Journal:  Int J Oncol       Date:  2015-06-16       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.